Utah Medical Products
UTMD
117 hedge funds and large institutions have $136M invested in Utah Medical Products in 2025 Q3 according to their latest regulatory filings, with 14 funds opening new positions, 39 increasing their positions, 34 reducing their positions, and 8 closing their positions.
75% more first-time investments, than exits
New positions opened: 14 | Existing positions closed: 8
15% more repeat investments, than reductions
Existing positions increased: 39 | Existing positions reduced: 34
11% more capital invested
Capital invested by funds: $123M → $136M (+$13.6M)
4% more funds holding
Funds holding: 112 → 117 (+5)
1.15% more ownership
Funds ownership: 66.47% → 67.62% (+1.2%)
0% more funds holding in top 10
Funds holding in top 10: 1 → 1 (0)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
BIP
Brandes Investment Partners
La Jolla,
California
|
+$3.94M |
| 2 |
QCM
Quantinno Capital Management
New York
|
+$726K |
| 3 |
SBH
Segall Bryant & Hamill
Chicago,
Illinois
|
+$682K |
| 4 |
OSAM
O'Shaughnessy Asset Management
Stamford,
Connecticut
|
+$513K |
| 5 |
AQR Capital Management
Greenwich,
Connecticut
|
+$401K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Geode Capital Management
Boston,
Massachusetts
|
-$1.47M |
| 2 |
Renaissance Technologies
New York
|
-$734K |
| 3 |
Los Angeles Capital Management
Los Angeles,
California
|
-$665K |
| 4 |
Millennium Management
New York
|
-$557K |
| 5 |
Citadel Advisors
Miami,
Florida
|
-$533K |
UTMD Hedge Fund Activity: Q3 2025 in Review
117 of the 7,621 institutional investors tracked by Wall St. Rank reported a position in Utah Medical Products (UTMD) for Q3 2025, worth a combined $136M — up 11% from $123M a quarter earlier.
Buyers outnumbered sellers: 14 funds opened new UTMD positions and 8 closed out — a net gain of 6 holders — while 39 added to existing stakes and 34 trimmed.
The largest buyer was Brandes Investment Partners, adding an estimated $3.94M. The largest seller was Geode Capital Management, cutting an estimated $1.47M.
- 117 institutional investors held Utah Medical Products (UTMD) as of Q3 2025, up from 112 in Q2 2025.
- Funds reported $136M of Utah Medical Products stock for Q3 2025, up 11% quarter-over-quarter.
- 14 funds opened new Utah Medical Products positions in Q3 2025 and 8 closed out, a net change of +6 holders.
- The largest Utah Medical Products buyer in Q3 2025 was Brandes Investment Partners, an estimated $3.94M added.
- The largest Utah Medical Products seller in Q3 2025 was Geode Capital Management, an estimated $1.47M sold.
Based on aggregated 13F filings for Q3 2025.